Endovascular management of acute deep vein thrombosis

被引:19
作者
Blum, A [1 ]
Roche, E [1 ]
机构
[1] Midwest Heart Specialists, Div Vasc Intervent Radiol, Elmhurst, IL 60126 USA
关键词
deep vein thrombosis; low-molecular-weight heparin; postthrombotic syndrome; unfractionated heparin;
D O I
10.1016/j.amjmed.2005.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The goals of successful management of deep vein thrombosis (DVT) include relief of acute symptoms with restoration of venous patency, prevention of clot propagation and subsequent pulmonary embolism, and maintenance of venous valvular function. Valvular incompetence is the leading cause of postthrornbotic syndrome (PTS), which is characterized by chronic leg heaviness and aching, lower extremity edema, and impaired viability of Subcutaneous tissues, which may lead to chronic trophic skin changes and venous ulceration. Anticoagulation with unfractionated or low-molecular-weight heparin followed by warfarin is recognized as the standard therapy for acute DVT. Although this approach may effectively prevent recurrent thrombosis, it often fails to meet the other treatment goals. Recent studies have demonstrated that early clot lysis through the use of catheter-directed thrombolytic therapy and other adjunctive endovascular techniques rapidly restores venous patency, more effectively preserves valvular function, and improves quality of life. When used in conjunction with anticoagulation, these minimally invasive endovascular techniques have the potential to lead to improved long-term outcomes in patients with DVT. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:31S / 36S
页数:6
相关论文
共 21 条
[1]  
ARNESEN H, 1982, ACTA MED SCAND, V211, P65
[2]   Cos of long-term complications of deep venous thrombosis of the lower extremities: An analysis of a defined patient population in Sweden [J].
Bergqvist, D ;
Jendteg, S ;
Johansen, L ;
Persson, U ;
Odegaard, K .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (06) :454-457
[3]   Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life [J].
Comerota, AJ ;
Throm, RC ;
Mathias, SD ;
Haughton, S ;
Mewissen, M .
JOURNAL OF VASCULAR SURGERY, 2000, 32 (01) :130-137
[4]  
Comerota AJ., 1992, SEMIN VASC SURG, V5, P76
[5]   A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism -: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency [J].
Dolovich, LR ;
Ginsberg, JS ;
Douketis, JD ;
Holbrook, AM ;
Cheah, G .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (02) :181-188
[6]   COMPARATIVE RANDOMIZED TRIAL OF HEPARIN VERSUS STREPTOKINASE IN THE TREATMENT OF ACUTE PROXIMAL VENOUS THROMBOSIS - INTERIM-REPORT OF A PROSPECTIVE TRIAL [J].
ELLIOT, MS ;
IMMELMAN, EJ ;
JEFFERY, P ;
BENATAR, SR ;
FUNSTON, MR ;
SMITH, JA ;
SHEPSTONE, BJ ;
FERGUSON, AD ;
JACOBS, P ;
WALKER, W ;
LOUW, JH .
BRITISH JOURNAL OF SURGERY, 1979, 66 (12) :838-843
[7]   Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial [J].
Elsharawy, M ;
Elzayat, E .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 24 (03) :209-214
[8]   Antithrombotic therapy for venous thromboembolic disease [J].
Hyers, TM ;
Agnelli, G ;
Hull, RD ;
Morris, TA ;
Samama, M ;
Tapson, V ;
Weg, JG .
CHEST, 2001, 119 (01) :176S-193S
[9]  
KILLEWICH LA, 1985, ARCH SURG-CHICAGO, V120, P424
[10]   A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis [J].
Levine, M ;
Gent, M ;
Hirsh, J ;
Leclerc, J ;
Anderson, D ;
Weitz, J ;
Ginsberg, J ;
Turpie, AG ;
Demers, C ;
Kovacs, M ;
Geerts, W ;
Kassis, J ;
Desjardins, L ;
Cusson, J ;
Cruickshank, M ;
Powers, P ;
Brien, W ;
Haley, S ;
Willan, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :677-681